A Strong European API Industry Can Achieve Strategic Autonomy of the EU Health System

9 November 2022

Report

New pricing models for generic medicines to ensure long-term healthy competitiveness in Europe

30 June 2022

Report

  New pricing models for generic medicines to ensure long-term […]

Removing access barriers in Central and Eastern Europe – April 2022

25 April 2022

Report

Eco-Pharmaco-Stewardship (EPS) initiative – Care for People and Our Environment

30 September 2021

Report

Market Review – European Generic Medicine Markets 2020

1 March 2021

Report

Electronic product information: from principles to actions. AESGP, EFPIA and Medicines for Europe reflections on EMAHMA – EC Key principles for electronic product information

10 February 2021

Report

Filling the gap: How off-patent medicines can improve the equity and quality of cancer care

4 February 2021

Report

White Paper: Anatomy of a failure to launch: A review of barriers to generic and biosimilar market entry and the use of competition law as a remedy

5 November 2020

Report

COVID-19 “Round 2” – Findings & way forward (Kearney)

22 June 2020

Report

Why is Now the Right Time to Modernise the Eu Variations System?

30 January 2020

Report